Key Takeaways

GLP-1 drugs offer potentially extensive benefits to people with psoriasis

Psoriasis patients had a 78% lower risk of death and 44% lower risk of heart problems on the drugs

They also were less likely to suffer from substance abuse

THURSDAY, Sept. 18, 2025 (HealthDay News) — People with psoriasis might receive unexpected benefits from cutting-edge weight loss drugs like Ozempic and Zepbound , a new study says.

Psoriasis patients taking GLP-1 drugs had a 78% lower risk of premature death and a 44% lower risk of heart attack, stroke or other heart-related health crisis, researchers reported Thursday at a meeting of the European Academy of Dermatology and Venereology in Paris.

These patients also had a 65% lower risk of alcohol abuse and nearly 50% lower risk of subst

See Full Page